Table 1.
The relationship between CLDN10 and clinicopathologic characteristics in validated cohort.
| Clinicopathologic characteristics | Low expression (%) | High expression (%) | X2 | P |
|---|---|---|---|---|
| Age | 0.150 | 0.698 | ||
| ≤45 | 12(44.4) | 11(30.3) | ||
| >45 | 15(55.6) | 17(69.7) | ||
| Gender | 4.199 | 0.400 | ||
| Female | 13(48.1) | 21(75) | ||
| Male | 14(51.9) | 7(25) | ||
| Tumor size | 0.034 | 0.853 | ||
| ≤10mm | 9(33.3) | 10(35.7) | ||
| >10mm | 18(66.7) | 18(64.3) | ||
| Unilateral or Bilateral | 0.181 | 0.671 | ||
| Unilateral | 11(40.7) | 13(46.4) | ||
| Bilateral | 16(59.3) | 15(53.6) | ||
| Extrathyroidal invasion | 0.392 | 0.531 | ||
| YES | 2(7.4) | 1(3.6) | ||
| NO | 25(92.6) | 27(96.4) | ||
| Lymph node metastasis | 3.104 | 0.078* | ||
| YES | 13(48.1) | 20(71.4) | ||
| NO | 14(51.9) | 8(28.6) | ||
| AJCC | 0.437 | 0.509 | ||
| I+II | 15(55.6) | 18(64.3) | ||
| III+IV | 12(44.4) | 10(35.7) | ||
* P-value < 0.05